Therapeutic strategies to optimize bone metabolism in anorexia nervosa
Authors:
Ľ. Tichá 1; J. Payer 2; Z. Killinger 2; Ľ. Podracká 1
Authors place of work:
Detská klinika LFUK a DFNsP, Bratislava
1; V. interná klinika LFUK a UN, Bratislava
2
Published in the journal:
Čes-slov Pediat 2017; 72 (4): 223-227.
Category:
Summary
The occurrence of anorexia nervosa at the critical time when peak bone mass (PBM) is accrued, significantly interferes with bone metabolism and represents lifelong burden and risk for developing of premature osteoporosis. Nutritional refeeding, dietary intake allowance for calcium and vitamin D, together with spontaneous restoration of menstrual function is the safest and the most effective strategy for improvement of bone mineral density. Physical activity should be regulated according to the stage of recovery. „Physiological“ estrogen replacement increases bone mineral density, but does not reach the "catch-up". Potential therapy strategies (recombinant IGF-1, bisphosphonates) have been investigated. Long-term persistence of the disease and frequent relapses delay the recovery, as well as the normalization of bone metabolism.
Key words:
anorexia nervosa, bone metabolism, potential therapy strategies
Zdroje
1. Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008; 93 (4): 1231–1237.
2. Payer J, Killinger Z, et al. Osteoporóza. Bratislava: Herba, 2012: 1–264. ISBN 978-80-89171-84-1.
3. Tichá Ľ, Payer J, Killinger Z, Podracká Ľ. Porucha kostného metabolizmu pri mentálnej anorexii. Čes-slov Pediat 2016; 71: 287–292.
4. García-De Alvaro MT, Muñoz-Calvo MT, Martínez G, et al. Regional skeletal bone deficit in female adolescents with anorexia nervosa: influence of the degree of malnutrition and weight recovery in a two year longitudinal study. J Pediatr Endocrinol Metab 2007; 20 (11): 1223–1231.
5. Compston JE, McConachie C, Stott C, et al. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 2006; 17 (1): 77–84.
6. Bachrach LK, Katzman DK, Litt IF, et al. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991; 72 (3): 602–606.
7. Sonneville KR, Gordon CM, Kocher MS, et al. Vitamin D, calcium, and dairy intakes and stress fractures among female adolescents. Arch Pediatr Adolesc Med 2012; 166 (7): 595–600.
8. Soyka LA, Grinspoon S, Levitsky LL, et al. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999; 84 (12): 4489–4496.
9. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int 2008; 19 (3): 289–294.
10. Frost HM. Bone’s mechanostat: A 2003 update. Anat Rec 2003; 275A (2): 1081–1101.
11. Zofková I. Hormonal aspects of the muscle-bone unit. Physiol Res 2008; 57 (Suppl 1): S159–69.
12. Christo K, Prabhakaran R, Lamparello B, et al. Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics 2008; 121 (6): 1127–1136.
13. Misra M, Golden NH, Katzman DK. State of the art systematic review of bone disease in anorexia nervosa. Int J Eat Disord 2016; 49: 276–292.
14. Klibanski A, Biller BM, Schoenfeld DA, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80 (3): 898–904.
15. Strokosch GR, Friedman AJ, Wu SC, Kamin M. Effects of an oral contraceptive (Norgestimate/Ethinyl Estradiol) on bone mineral density in adolescent females with anorexia nervosa: A double-blind, placebo-controlled study. J Adolesc Health 2006; 39 (6): 819–827.
16. Misra M, Katzman D, Miller KK, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011; 26 (10): 2430–2438.
17. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002; 87 (11): 4935–4941.
18. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 2005; 90 (3): 1428–1433.
19. Fazeli PK, Lawson EA, Prabhakaran R, et al. Effects of recombinant human growth hormone in anorexia nervosa: A randomized, placebo-controlled study. J Clin Endocrinol Metab 2010; 95 (11): 4889–4897.
20. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002; 87 (6): 2883–2891.
21. Misra M, McGrane J, Miller KK, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 2009; 45 (3): 493–498.
22. Sienkiewicz E, Magkos F, Aronis KN, et al. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 2011; 60: 1211–1221.
23. Miller KK, Meenaghan E, Lawson EA, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011; 96 (7): 2081–2088.
24. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: A randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90 (6): 3179–3185.
25. Patlas N, Golomb G, Yaffe P, et al. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999; 60: 68–73.
26. Misra M, Klibanski A. Anorexia nervosa and bone. J Endocrinol 2014; 221 (3): 163–176.
27. Fazeli PK, Wang IS, Miller KK, et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab 2014; 99 (4): 1322–1329.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2017 Číslo 4
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Osteogenesis imperfecta – state of art
-
Infantile hemangiomas.
Current treatment procedures - Hypophosphatasia – skeletal disease requiring our attention
- Tolerogenic dendritic cells and their application in immunopathological processes